Received Nov 24, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | UNK | — |
Aches; Chills; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of pain in a patient who received Herpes zoster (Shingrix) for prophylaxis. On 18-NOV-2025, the patient received the 1st dose of Shingrix. In NOV-2025, less than a week after receiving Shingrix, the patient experienced pain (Verbatim: Aches) and chills (Verbatim: Chills). The outcome of the pain and chills were not reported. It was unknown if the reporter considered the pain and chills to be related to Shingrix. It was unknown if the company considered the pain and chills to be related to Shingrix. Additional Information: GSK Receipt Date: 19-NOV-2025 This case was reported by a patient via interactive digital media. The patient reported that he had received the first dose of Shingrix vaccine yesterday and had really bad chills and aches and the patient was concerned about getting the second dose. The batch number was not provided, and we are unable to contact the reporter.